Answers are grounded in this paper and cite their sources.
Extrachromosomal circular DNA (eccDNA) is an essential type of circular DNA that is mainly characterized by independence from chromosomes and a broad size distribution. Increasing evidence suggests that the distinctive genomic distribution of eccDNA establishes it as a clinical biomarker. Nevertheless, the molecular mechanisms underlying its biogenesis and function in tumorigenesis have not been fully elucidated. Thus, in this review, we summarize the emerging insights into the biogenesis mechanisms of eccDNA, with particular emphasis on the recently described single-strand break driven internal loop (i-loop) model. We also discuss its critical roles in oncogenesis, including oncogene amplification, tumor heterogeneity, cell death, tumor immunity and drug resistance. We further outline current detection methods for eccDNA and evaluate its potential as a promising diagnostic, prognostic and predictive biomarker for human cancers, as well as a therapeutic vulnerability with implications for chemotherapy, radiotherapy, immunotherapy and nanotherapy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: